The technology R&D center is a professional department engaged in the research and development of new products, new processes and new materials, mainly responsible for the development of the company's science and technology projects and the management of intellectual property rights. Adhering to the concept of "innovation is the inexhaustible driving force of enterprise development", the center gives priority to researching, learning and absorbing advanced technology, transforming technology into productivity and serving the market and customers.

Center of "industrial application test of rare earth anti-bacterial materials research", "due to the close system of rare earth polishing agent for technology", "one-step synthesis of 1 micron grade fluoride lanthanum cerium polishing powder preparation technology research", "atmospheric pressure synthesis of feasibility study and application of high purity anhydrous rare earth chloride", "the preparation and application of boride rare earth luminescence materials" project conducted in-depth research, Accumulated a number of strong technical strength for the company's sustainable development to provide sufficient power. Some of the research achievements of the center are applying for patents, among which the patent application of "a rare earth composite antibacterial material and its preparation method" has been accepted by the State Intellectual Property Office.

The technical r&d personnel of the company have professional education and foundation, engaged in the research and development of rare earth compounds and oxides with special physical properties for many years, participated in the invention and creation of a number of rare earth related patents, and have rich experience in the purification and impurity removal of rare earth. At the same time, 3 authoritative experts in rare earth industry are employed as technical consultants of the company, among which 2 are senior engineers.

On May 30, 2022, the company and xi 'an ShenLan biomedical engineering co., LTD., through friendly negotiations, in line with the "complementary advantages, upstream and downstream industry linkage and common development, cooperation and win-win" principle, on the premise of equality, voluntary, the two sides agreed to rare earth compounds, rare earth antibacterial materials in areas such as biomedical applications, establish technical exchanges, technical research and development, Cooperation in product mutual inspection, production line optimization, personnel training, scientific and technological project cooperation, and jointly promote the application of rare earth new materials in biomedicine and other fields.